Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

14,617 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Induction of phase I, II and III drug metabolism/transport by xenobiotics.
Xu C, Li CY, Kong AN. Xu C, et al. Arch Pharm Res. 2005 Mar;28(3):249-68. doi: 10.1007/BF02977789. Arch Pharm Res. 2005. PMID: 15832810 Review.
Activation of Nrf2-antioxidant signaling attenuates NFkappaB-inflammatory response and elicits apoptosis.
Li W, Khor TO, Xu C, Shen G, Jeong WS, Yu S, Kong AN. Li W, et al. Among authors: xu c. Biochem Pharmacol. 2008 Dec 1;76(11):1485-9. doi: 10.1016/j.bcp.2008.07.017. Epub 2008 Jul 23. Biochem Pharmacol. 2008. PMID: 18694732 Free PMC article. Review.
Synergistic effects of a combination of dietary factors sulforaphane and (-) epigallocatechin-3-gallate in HT-29 AP-1 human colon carcinoma cells.
Nair S, Hebbar V, Shen G, Gopalakrishnan A, Khor TO, Yu S, Xu C, Kong AN. Nair S, et al. Among authors: xu c. Pharm Res. 2008 Feb;25(2):387-99. doi: 10.1007/s11095-007-9364-7. Epub 2007 Jul 27. Pharm Res. 2008. PMID: 17657594
Toxicogenomics of endoplasmic reticulum stress inducer tunicamycin in the small intestine and liver of Nrf2 knockout and C57BL/6J mice.
Nair S, Xu C, Shen G, Hebbar V, Gopalakrishnan A, Hu R, Jain MR, Liew C, Chan JY, Kong AN. Nair S, et al. Among authors: xu c. Toxicol Lett. 2007 Jan 10;168(1):21-39. doi: 10.1016/j.toxlet.2006.10.012. Epub 2006 Nov 10. Toxicol Lett. 2007. PMID: 17127020 Free PMC article.
In vivo pharmacokinetics, activation of MAPK signaling and induction of phase II/III drug metabolizing enzymes/transporters by cancer chemopreventive compound BHA in the mice.
Hu R, Shen G, Yerramilli UR, Lin W, Xu C, Nair S, Kong AN. Hu R, et al. Among authors: xu c. Arch Pharm Res. 2006 Oct;29(10):911-20. doi: 10.1007/BF02973914. Arch Pharm Res. 2006. PMID: 17121188
In addition, BHA activated distinct mitogen-activated protein kinases (MAPKs), c-Jun N-terminal kinase (JNK), extracellular signal-regulated protein kinase (ERK), as well as p38, suggesting that the MAPK pathways may play an important role in early signaling events leading …
In addition, BHA activated distinct mitogen-activated protein kinases (MAPKs), c-Jun N-terminal kinase (JNK), extracellular signal-re …
Induction of heme oxygenase-1 (HO-1) and NAD[P]H: quinone oxidoreductase 1 (NQO1) by a phenolic antioxidant, butylated hydroxyanisole (BHA) and its metabolite, tert-butylhydroquinone (tBHQ) in primary-cultured human and rat hepatocytes.
Keum YS, Han YH, Liew C, Kim JH, Xu C, Yuan X, Shakarjian MP, Chong S, Kong AN. Keum YS, et al. Among authors: xu c. Pharm Res. 2006 Nov;23(11):2586-94. doi: 10.1007/s11095-006-9094-2. Epub 2006 Oct 18. Pharm Res. 2006. PMID: 17048120
Pharmacogenomics of phenolic antioxidant butylated hydroxyanisole (BHA) in the small intestine and liver of Nrf2 knockout and C57BL/6J mice.
Nair S, Xu C, Shen G, Hebbar V, Gopalakrishnan A, Hu R, Jain MR, Lin W, Keum YS, Liew C, Chan JY, Kong AN. Nair S, et al. Among authors: xu c. Pharm Res. 2006 Nov;23(11):2621-37. doi: 10.1007/s11095-006-9099-x. Epub 2006 Sep 13. Pharm Res. 2006. PMID: 16969697
Pharmacogenomics of cancer chemopreventive isothiocyanate compound sulforaphane in the intestinal polyps of ApcMin/+ mice.
Khor TO, Hu R, Shen G, Jeong WS, Hebbar V, Chen C, Xu C, Nair S, Reddy B, Chada K, Kong AN. Khor TO, et al. Among authors: xu c. Biopharm Drug Dispos. 2006 Dec;27(9):407-20. doi: 10.1002/bdd.522. Biopharm Drug Dispos. 2006. PMID: 16952200
Mechanism of action of sulforaphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells.
Keum YS, Yu S, Chang PP, Yuan X, Kim JH, Xu C, Han J, Agarwal A, Kong AN. Keum YS, et al. Among authors: xu c. Cancer Res. 2006 Sep 1;66(17):8804-13. doi: 10.1158/0008-5472.CAN-05-3513. Cancer Res. 2006. PMID: 16951197
Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2.
Xu C, Yuan X, Pan Z, Shen G, Kim JH, Yu S, Khor TO, Li W, Ma J, Kong AN. Xu C, et al. Mol Cancer Ther. 2006 Aug;5(8):1918-26. doi: 10.1158/1535-7163.MCT-05-0497. Mol Cancer Ther. 2006. PMID: 16928811
In the present study, we investigated the roles of extracellular signal-regulated kinase (ERK) and c-Jun-NH(2)-kinase (JNK) in the regulation of phenethyl isothiocyanate (PEITC)-induced and Nrf2-dependent ARE activity and ARE-driven heme oxygenase-1 (HO-1) gene expression …
In the present study, we investigated the roles of extracellular signal-regulated kinase (ERK) and c-Jun-NH(2)-kinase (JNK) in the re …
14,617 results
Jump to page
Feedback